EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bayesian benchmark dose modeling analysis and derivation of points of departure for female reproductive toxicity following exposure to di(2-ethylhexyl) phthalate (DEHP) — effects on reproductive hormones, folliculogenesis and estrous cyclicity

Antero Vieira Silva iD, Ilari Tarvainen iD, Mattias Öberg iD, Mary Laws iD, Patrick Hannon iD, Jodi Flaws iD, Pauliina Damdimopoulou iD

Toxicological Sciences · 01.07.2025 · 206 (1) · 30-45

DOI: 10.1093/toxsci/kfaf052 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxicological Sciences, online erschienen am 21.04.2025. Verfasst von Antero Vieira Silva und 6 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Integrative Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm 171 65, Sweden. Hauptthemen laut MEDLINE: Diethylhexyl Phthalate, Estrous Cycle, Ovarian Follicle, Reproduction. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FORMAS, NIEHS NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endocrine-disrupting chemicals such as di(2-ethylhexyl) phthalate (DEHP) pose significant risks to human reproductive health. However, regulatory frameworks often lack sufficient data on sensitive female-specific reproductive endpoints. This study investigates the sensitivity of hypothalamic–pituitary–ovarian (HPO) axis endpoints to DEHP exposure in adult female mice, applying Bayesian Benchmark dose (BBMD) modeling for dose–response assessment and derivation of points-of-departure (PODs) for risk assessment. Data from four studies where sexually mature female mice were exposed to DEHP (0.02 to 240 mg/kg bw/d) for 10 or 30 d via oral administration, or 30 d via diet, was modeled. Endpoints included ovarian follicle counts, serum hormones, estrous cyclicity, body, and organ weights. Results revealed dose-dependent changes and greater sensitivity of progesterone, ovarian follicle counts, and uterine weight, compared with estrous cyclicity, body weight, and other organ weights. For 10- and 30-d oral administration studies, the lowest nonzero BBMDLs were observed for serum progesterone levels (9.1 mg/kg bw/d) and primary follicle counts (19.5 mg/kg bw/d), respectively. These PODs were notably lower than most No-Adverse-Effect-Levels in the European Chemicals Agency’s (ECHA’s) “Registered substances factsheet” and “ECHA CHEM” databases. The majority of the studies derived PODs based on male (reproductive) endpoints. Finally, a derived no-effect level of 0.064 mg DEHP/kg bw/d was estimated, based on the overall lowest BBMDL, serum progesterone levels of the 10-d oral study. In conclusion, our study indicates that current guidelines may not fully capture reproductive risks for females, underscoring the need to refine regulatory endpoints to better protect female reproductive health in the context of DEHP exposure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diethylhexyl PhthalateEstrous CycleOvarian FollicleReproductionEndocrine DisruptorsAnimalsFemaleBayes TheoremDose-Response Relationship, DrugMiceBenchmarkingRisk AssessmentOrgan SizeProgesterone

Stichwörter der Autor:innen

benchmark dose (BMD)di(2-ethylhexyl) phthalate (DEHP)endocrine disrupting chemicalsestrous cyclicityfolliculogenesishypothalamus–pituitary–gonadal axisovarian folliclesreproductive toxicity

Substanzen

Diethylhexyl PhthalateEndocrine DisruptorsProgesterone

Autor:innen und Institutionen

  • Unit of Integrative Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm 171 65, Sweden.
  • Department of Women's and Children's Health, BioMedicum, Karolinska Institutet, Stockholm 171 65, Sweden.
  • Department of Obstetrics and Gynecology, University of Helsinki, Helsinki University Central Hospital, Helsinki 00290, Finland.
  • Department of Comparative Biosciences, University of Illinois Urbana-Champaign, Urbana, IL 61802, United States.
  • Department of Obstetrics & Gynecology, College of Medicine, University of Kentucky, Lexington, KY 40508, United States.
  • Carl R. Woese Institute for Genomic Biology, University of Illinois Urbana-Champaign, Urbana, IL 61801, United States.

ORCID-Profile: Antero Vieira Silva, Ilari Tarvainen, Mattias Öberg, Mary Laws, Patrick Hannon, Jodi Flaws, Pauliina Damdimopoulou

Förderung

  • FORMAS
  • NIEHS NIH HHS
  • NIH HHS
  • NIH

Zitieren

APA

Silva, A. V., Tarvainen, I., Öberg, M., Laws, M., Hannon, P., Flaws, J., & Damdimopoulou, P. (2025). Bayesian benchmark dose modeling analysis and derivation of points of departure for female reproductive toxicity following exposure to di(2-ethylhexyl) phthalate (DEHP) — effects on reproductive hormones, folliculogenesis and estrous cyclicity. Toxicological Sciences, 206(1), 30-45. https://doi.org/10.1093/toxsci/kfaf052

Vancouver

Silva AV, Tarvainen I, Öberg M, Laws M, Hannon P, Flaws J, et al. Bayesian benchmark dose modeling analysis and derivation of points of departure for female reproductive toxicity following exposure to di(2-ethylhexyl) phthalate (DEHP) — effects on reproductive hormones, folliculogenesis and estrous cyclicity. Toxicological Sciences. 2025;206(1):30-45. doi:10.1093/toxsci/kfaf052

BibTeX
@article{Silva2025,
  author = {Silva, Antero Vieira and Tarvainen, Ilari and Öberg, Mattias and Laws, Mary and Hannon, Patrick and Flaws, Jodi and Damdimopoulou, Pauliina},
  title = {Bayesian benchmark dose modeling analysis and derivation of points of departure for female reproductive toxicity following exposure to di(2-ethylhexyl) phthalate (DEHP) — effects on reproductive hormones, folliculogenesis and estrous cyclicity},
  journal = {Toxicological Sciences},
  year = {2025},
  volume = {206},
  number = {1},
  pages = {30--45},
  doi = {10.1093/toxsci/kfaf052}
}
Kostenlos starten →